These outcomes, together with a earlier report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the idea of targeting ACKR3 as a unique technique to modulate the opioid process, which could open new therapeutic avenues for opioid-connected disorders. All of our content is reviewed https://conolidine33198.tdlwiki.com/665615/conolidine_an_overview